Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/02/2005 | CN1689556A Oral administered sustained release lozenge composition and its preparation method |
11/02/2005 | CN1225464C Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine |
11/02/2005 | CN1225287C Stabilized radiopharmaceutical composition |
11/02/2005 | CN1225284C Process for preparing poly lactic acid super microball carrying medicine |
11/02/2005 | CN1225282C Medicine for treating prolapse of lumber intervertebral disc |
11/02/2005 | CN1225280C Plaster for treating prolapse of intervertebral disc |
11/02/2005 | CN1225276C Preparation method of red peony root injection |
11/02/2005 | CN1225270C Medicine for treating atherosclerosis and its preparing method |
11/02/2005 | CN1225268C 'Sanhuang' dripping pills and preparing method thereof |
11/02/2005 | CN1225261C Spray for treating snore |
11/02/2005 | CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof |
11/02/2005 | CN1225249C Antivirus medicine for raising immunity and its preparation method |
11/02/2005 | CN1225248C Antineoplastic effect of a group of cycloart-one triterpene compound |
11/02/2005 | CN1225247C Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn. |
11/02/2005 | CN1225246C Releasing improved pharmaceutical preparation containing amoxicillin |
11/02/2005 | CN1225241C Method for preparing oral disintegrating tablet |
11/02/2005 | CN1225240C Enteric coated particle preparation containing 2-[(4-methoxy-3-methyl)-2- pyridyl] methyl sulfenyl-5-(1H-pyrrole-1-radical)-1H-benzimidazole |
11/02/2005 | CN1225239C Fimbriate orostachys herb suppository and its preparing process |
11/02/2005 | CN1225230C High viscosity liquid controlled delivery system |
11/02/2005 | CN1225217C Application of Acer truncatum extract as cigarette free radical scavenger and corresponding cigarette |
11/02/2005 | CN1225198C Heat-clearing factor |
11/01/2005 | US6960617 Mixing ethylenically-unsaturated monomer and multi-olefinic crosslinking agent; subjecting to polymerization conditions and foaming to form composite; combining at least one strengthening agent |
11/01/2005 | US6960564 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
11/01/2005 | US6960563 Spontaneous emulsions containing cyclosporine |
11/01/2005 | US6960561 Polypeptide mixture containing preservative, surfactant and stabilizer |
11/01/2005 | US6960560 Iron chelator delivery system |
11/01/2005 | US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
11/01/2005 | US6960357 Controlled release; drugs mixed with inert ingredients compressed into tablets |
11/01/2005 | US6960356 tablet or capsule comprising a drug such as ciprofloxacin, acyclovir, diltiazem, ranitidine, or captopril, a gas generator, a swelling agent, a viscolyzing agent, and optional gel forming polymer; Controlled Gas Powered System; stomach retention |
11/01/2005 | US6960355 Modified amino acid compounds useful in delivery of active agents |
11/01/2005 | US6960353 Formulations for the transdermal administration of fenoldopam |
11/01/2005 | US6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
11/01/2005 | US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
11/01/2005 | US6960350 Comprises aliphatic/aromatic alcohol and aliphatic/aromatic aldehyde; synergism; for use in room, closet or shoe box |
11/01/2005 | US6960346 Using citric acid esters or ethers |
11/01/2005 | US6960341 Bifidobacteria and preparations containing them |
11/01/2005 | US6960300 Process for preparing water soluble diterpenes and their applications |
11/01/2005 | US6960256 Formation of small crystals |
11/01/2005 | US6960251 Silica comprising at least two silica fractions, wherein said at least two silica fractions differ in value for surface area and oil absorption, in given ranges; good absorbency, low dust |
11/01/2005 | CA2457029C Breath freshening film |
11/01/2005 | CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors |
11/01/2005 | CA2264852C Use of methylphenidate or a pharmaceutically acceptable salt thereof |
11/01/2005 | CA2216371C Novel "burst-free" sustained release poly-(lactide/glycolide) microspheres |
11/01/2005 | CA2115792C Method for the treatment of pain |
11/01/2005 | CA2113242C Discharge and transfer system for apparatus for gelatin coating tablets |
10/28/2005 | WO2006131784A1 Body cavity foams |
10/28/2005 | CA2565754A1 Body cavity foams |
10/27/2005 | WO2005101466A2 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
10/27/2005 | WO2005100362A1 Liquid external preparation containing pranoprofen |
10/27/2005 | WO2005099889A1 Process for producing hollow nanoparticle with use of liposome as template |
10/27/2005 | WO2005099787A1 Coating compositions for bioactive agents |
10/27/2005 | WO2005099786A1 Coating compositions for bioactive agents |
10/27/2005 | WO2005099767A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations |
10/27/2005 | WO2005099766A1 Crosslinkable pressure-sensitive adhesive for the skin |
10/27/2005 | WO2005099765A1 Liquid composition and process for producing the same |
10/27/2005 | WO2005099764A1 Antifungal composition for external use |
10/27/2005 | WO2005099763A2 Composition for intracellular transfer of a nucleic acid |
10/27/2005 | WO2005099762A1 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability |
10/27/2005 | WO2005099761A1 Dietary supplement and method of processing same |
10/27/2005 | WO2005099760A1 Solid pharmaceutical preparation |
10/27/2005 | WO2005099751A2 Apparatus and method for transdermal delivery of influenza vaccine |
10/27/2005 | WO2005099732A1 Process for producing granule containing plant extract |
10/27/2005 | WO2005099728A1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use |
10/27/2005 | WO2005099718A1 Lung surfactant supplements |
10/27/2005 | WO2005099713A2 Novel antiviral pharmaceutical composition |
10/27/2005 | WO2005099708A1 Composition comprising itraconazole for oral administration |
10/27/2005 | WO2005099698A1 STABILIZED 4-AMINO-5-CHLORO-N-[(1R,3r,5S)-8-METHYL-8- AZABICYCLO[3.2.1]OCT-3-YL]-2-[1-METHYLBUT-2-YNYLOXY]-BENZAMIDE CONTAINING COMPOSITION |
10/27/2005 | WO2005099694A1 Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity |
10/27/2005 | WO2005099685A1 Liquid external preparation containing sodium cromoglycate |
10/27/2005 | WO2005099683A1 Antibacterial agent whose active ingredint is methyl paraoxybenzoate and composition for external application containing the same |
10/27/2005 | WO2005099681A1 Tablet containing branched chain amino acid and process for producing the same |
10/27/2005 | WO2005099677A1 Bazedoxifene acetate solid dispersion formulations |
10/27/2005 | WO2005099676A2 Transdermal delivery system for use with basic permeation enhancers |
10/27/2005 | WO2005099675A2 Sunscreen compositions with spf enhancer |
10/27/2005 | WO2005099674A1 Pharmaceutical compositions comprising an amphiphilic starch |
10/27/2005 | WO2005099673A1 Polycylic thiazoles as potassium ion channel modulators |
10/27/2005 | WO2005099672A1 A modified release pharmaceutical formulation comprising amoxicillin and clavulanate |
10/27/2005 | WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
10/27/2005 | WO2005099670A1 Method for administering medicaments to subjects with swallowing difficulties and disorders |
10/27/2005 | WO2005099669A1 Liquids containing suspended glass particles |
10/27/2005 | WO2005099668A2 Methods of manufacture and use of calcium phosphate particles containing allergens |
10/27/2005 | WO2005099667A2 Drug delivery compositions |
10/27/2005 | WO2005099666A2 Delayed release formulations of 6-mercaptopurine |
10/27/2005 | WO2005099665A2 Imroved formulations of 6-mercaptopurine |
10/27/2005 | WO2005099569A1 Article and method for applying a coupling agent for a non-invasive optical probe |
10/27/2005 | WO2005065685A8 Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer |
10/27/2005 | WO2005065645A3 Donepezil formulations |
10/27/2005 | WO2005065602A3 Drug delivery device with mechanical locking mechanism |
10/27/2005 | WO2005051902A3 Modified mscl protein channel |
10/27/2005 | WO2005051451A8 Electrical devices and anti-scarring agents |
10/27/2005 | WO2005051353A3 Pharmaceutical formulations comprising voriconazole |
10/27/2005 | WO2005046649A3 Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances |
10/27/2005 | WO2005046567B1 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same |
10/27/2005 | WO2005034972A3 Use of pharmaceutical compositions containing evening primrose oil for the treatment of xerostomia |
10/27/2005 | WO2005027852A3 Compositions of polyacids and polyethers and methods for their use in reducing pain |
10/27/2005 | WO2005011567A3 Foam carrier containing amphiphilic copolymeric gelling agent |
10/27/2005 | WO2005009225A3 Tissue adhesive sealant |
10/27/2005 | WO2004075854A3 Microbicidal compositions and method of use |
10/27/2005 | WO2004047797A8 Crystallization method and apparatus using an impinging plate assembly |
10/27/2005 | US20050240544 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network |